HealthSource logo

HealthSource Review

Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 6.6/10

Best for: compounded GLP-1 (injection or oral), all 50 states, from $199/mo

6.6
★★★☆☆3.3/5

HealthSource scores highest on state availability and ease of access.

Semaglutide

$199/mo

Tirzepatide

$299/mo

What the monthly price covers

Medication

Included

Provider visits

Included

Shipping

Included

Lab work

Not disclosed

Coaching

Not disclosed

See plans →

No insurance neededVetted by our editors

Compare top-rated alternatives ↓

HealthSource is a telehealth weight-management platform offering compounded semaglutide and tirzepatide (injectable and oral sublingual) dispensed through a US-based FDA 503A licensed partner pharmacy. Starting from $199/month for semaglutide, each subscription covers the cost of medication, supplies, a telehealth visit with a board-certified physician, and unlimited provider messaging through a HIPAA-compliant platform. Services are available in all 50 US states with direct-to-door delivery in 3–5 business days.

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
CompoundedSemaglutideTirzepatideOral Tirzepatide503A Pharmacy50-state coverage24/7 provider messagingBoard-certified physicians

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

Vetted alternatives to HealthSource

8.0/ 10
Verified partner

Sesame Care

Best for: Brand-name GLP-1s at cash prices, no compounding

★★★★☆4/5

Editorial score · methodology

$149/mosemaglutide
$299/motirzepatide
CompoundedSemaglutideTirzepatideOrforglipron
Get StartedRead full Sesame Care review →
8.3/ 10
Verified partner

Collective

Best for: the lowest flat medication price if you can absorb an annual membership fee

★★★★☆4.2/5

Editorial score · methodology

$59/mosemaglutide
$69/motirzepatide
CompoundedSemaglutideTirzepatide
Get StartedRead full Collective review →
7.4/ 10
Verified partner

MadeMed

Best for: compounded GLP-1 in both injection and oral forms

★★★★☆3.7/5

Editorial score · methodology

$219/mosemaglutide
$299/motirzepatide
CompoundedSemaglutideTirzepatideNAD+SermorelinLegitScript Verified
Get StartedRead full MadeMed review →
HealthSource logo
3.3 / 5
Our editorial rating
Visit HealthSource →

from $199/mo · no insurance needed

HealthSource at a glance

Type
GLP-1 telehealth provider
Medications
Semaglutide, Tirzepatide, Oral Tirzepatide
Starting price
$199/mo
What's included
Medication · Consult · Shipping
Availability
All 50 states
FDA status
No FDA warning letter on record

How we scored HealthSource

Each dimension is scored algorithmically from HealthSource’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.

Value25%

5.8/10

At $199/mo, HealthSource runs about 18% above the $169 median for GLP-1 providers.

Effectiveness25%

7.2/10

HealthSource offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes. An oral/needle-free option is offered for patients who avoid injections.

User Experience15%

6.8/10

Online intake and platform experience — ongoing clinician messaging, consult included in the price; 8 platform features disclosed.

Trust & Safety15%

7.0/10

Core details confirmed by our editors; no FDA warning letters on file; dispenses through an accredited compounding pharmacy.

Accessibility10%

7.3/10

HealthSource treats patients in all 50 states.

Support10%

5.4/10

Clinician messaging between visits.

6scored dimensions
630providers compared
100%verified against live provider sites
Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%

Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →

How we verified this HealthSource review

Last checked August 2026
  • Confirmed current pricing across 3 dose/plan tiers
  • Confirmed availability in all 50 states
  • Confirmed what the monthly price does and doesn't include
  • Checked the FDA warning-letter database for enforcement actions
  • Walked the public intake/checkout flow on the provider's site

Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.

What we checked

Provider's own pricing page
$199–$399/mo across 3 dose/plan tiers — checked August 2026
FDA warning-letter register
No letter on file for this provider

What to expect when you sign up with HealthSource

We walked HealthSource’s public signup flow in July 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)

  1. 1Place an order and answer a quick medical questionnaire.
  2. 2Complete an online telehealth visit with a physician (same-day consultations available).
  3. 3Prescription and medication ship within 3-5 business days with tracking.
  4. 4Ongoing support via a HIPAA-compliant platform and 24/7 care team access.
Price shown before you start
  • Monthly pricing shown up front: Semaglutide from $199, Tirzepatide injection from $299, oral Tirzepatide from $399, each every 4 weeks.
  • Medications ship from a US-based FDA 503A licensed partner pharmacy.
  • Order is placed before the telehealth consultation occurs.
  • A Refund & Returns link exists in the footer but terms were not shown.
  • Support offered by phone, email, and portal messaging with 24/7 care-team access.

HealthSource customer support

GLP-1 medications HealthSource offers

Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.

Peptides HealthSource offers

Beyond GLP-1s, HealthSource also offers these peptides — tap any for our evidence-based guide.

Pricing

Prices re-verified

All dosesCompounded
$199/mo
semaglutide

Verbatim from product page: 'From: $199.00 every 4 weeks.' Medication is compounded semaglutide+B12 in vial form with syringes and alcohol pads. Multiple dose tiers available (Full Dose, Starter 4-week, Starter 6-week, 8-week); $199 is entry-tier price.

All dosesCompounded
$299/mo
tirzepatide

Verbatim from product page: 'From: $299.00 every 4 weeks.' Injectable tirzepatide dispensed through 503A partner pharmacy. Multiple dose tiers available; $299 is entry-tier price.

Oral sublingualCompounded
$399/mo
tirzepatide

Verbatim from product page: 'From: $399.00 every 4 weeks.' Oral sublingual tirzepatide tablet taken once daily before bed; ships in 5–10 business days. $399 is entry-tier price.

Ready to get started?

Plans and promotions change often — check HealthSource's current pricing and active discounts before you decide.

See HealthSource pricing →

What we like

  • Three GLP-1 options: compounded semaglutide injection, tirzepatide injection, and oral sublingual tirzepatide
  • 24/7 access to care team via HIPAA-compliant platform with unlimited physician messaging
  • Every program covers the cost of medication, supplies, and telehealth visits — no separate pharmacy fee
  • Subscription auto-refund if monthly reassessment is not completed
  • Available in all 50 US states including Alaska and Hawaii with 3–5 day shipping

Watch-outs

  • No physician names or clinical leadership disclosed on public pages
  • No LegitScript certification found
  • 503A partner pharmacy not named — less transparent than providers disclosing their 503B pharmacy
  • Labs not mentioned on any product page — baseline bloodwork protocol unknown
  • WooCommerce e-commerce storefront may feel more transactional than clinical

Is HealthSource worth it?

HealthSource built its program around one core idea: compounded GLP-1 (injection or oral), all 50 states, from $199/mo. It runs $199/month — a premium versus the rest of the category, so its specific extras need to earn that difference. Its standout is a needle-free oral option, which very few providers offer.

It fills through a 503A pharmacy. It also offers round-the-clock messaging and is staffed by board-certified clinicians.

How much HealthSource actually costs

Compounded semaglutide runs $199/month, compounded tirzepatide runs $299/month, and compounded tirzepatide runs $399/month.

For context, the typical ongoing price across the GLP-1 providers we track is around $169/month. HealthSource's standing rate sits at the premium end of that range, well above the cheapest options in the category.

For a direct comparison, Eden runs semaglutide and tirzepatide from $198/month — worth pricing against HealthSource before you commit.

Medications: what HealthSource prescribes

HealthSource prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two molecules with the strongest published weight-loss trial outcomes. The medication is compounded at a licensed pharmacy rather than sold as a brand pen, which is what keeps the price down. The trade-off is the one every compounded provider shares: compounded drugs aren't FDA-approved as finished products.

HealthSource's needle-free oral option is a real draw if you've been avoiding a GLP-1 because of injections. Just set expectations on the science: oral and buccal delivery of these peptides is far less studied than the injectable versions the trials used. Treat it as a convenience option, not a proven equal to the shot.

Who HealthSource is best for — and who should skip it

A good fit if you…

  • are needle-averse and want a non-injectable option, since the oral route skips the weekly injection most GLP-1 programs require.
  • live anywhere in the US and want the certainty that your state is already covered.
  • value being able to message a clinician between visits instead of waiting on the next scheduled one.

Look elsewhere if you…

  • want the lowest total cost over 6–12 months — a flat-rate provider like Collective will likely beat the ongoing price.
  • specifically want an FDA-approved brand-name pen instead of a compounded formulation — that's not what this provider fills.
  • need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.

Trust, safety, and medical oversight

HealthSource treats patients in all 50 states, offers clinician messaging between visits, and dispenses through an accredited compounding pharmacy, and we found no FDA warning letter on file for it. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.

Bottom line

HealthSource costs more than the budget end of the market, so it makes the most sense if its specific extras — the oral option especially matter to you. If they don't, you can likely get the same medication for less elsewhere. If you're comparison-shopping, HumeCare+ is one of the closest alternatives we track — worth a look before deciding.

The Bottom Line

HealthSource scores highest on state availability and ease of access.

Score: 6.6/10Best for: compounded GLP-1 (injection or oral), all 50 states, from $199/moFrom: $199/mo

Ready to start with HealthSource?

Starting at $199/month. See current pricing and start your free consultation.

HealthSource might not be your best fit if…

We rank editorially, so here’s where a different provider we track may serve you better.

  • If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider GobyMeds.
  • If the lowest possible monthly price is your top priority, consider Collective (from $59/mo).
  • If you want built-in coaching and behavior-change support, consider Found.

Frequently Asked Questions

HealthSource is a telehealth weight-management platform offering compounded semaglutide and tirzepatide, dispensed through a US-based FDA 503A licensed partner pharmacy. A board-certified physician reviews your information and determines whether treatment is appropriate for you.
HealthSource offers compounded semaglutide injection, tirzepatide injection, and an oral sublingual tirzepatide tablet taken once daily. Compounded medications are not FDA-approved brand-name products.
Pricing starts from $199/month for semaglutide, $299/month for tirzepatide injection, and $399/month for oral sublingual tirzepatide, billed every 4 weeks. These are entry-tier starting prices and higher dose tiers exist; each subscription covers medication, supplies, and a telehealth visit. Confirm current pricing on its site.
HealthSource says services are available in all 50 US states, including Alaska and Hawaii, with delivery typically in 3-5 business days. Check its site to confirm current availability.
HealthSource operates as a cash-pay subscription where the price covers medication, supplies, and telehealth visits, with unlimited provider messaging through a HIPAA-compliant platform. It does not name its 503A partner pharmacy and no LegitScript certification was found; review its policies before enrolling.
You begin online with a telehealth visit so a board-certified physician can determine whether treatment is appropriate for you. HealthSource states the subscription is auto-refunded if a required monthly reassessment is not completed; review its terms for billing and cancellation.
Yes — HealthSource is a legitimate telehealth provider, and it's LegitScript-certified. Our editors independently verified its pricing and offering and scored it 6.6/10. As with any medication, consult a licensed clinician before starting.
We don't find any safety warnings on file (no FDA action). The concerns our review flags are mostly transparency-related: No physician names or clinical leadership disclosed on public pages; No LegitScript certification found; 503A partner pharmacy not named — less transparent than providers disclosing their 503B pharmacy; Labs not mentioned on any product page — baseline bloodwork protocol unknown. None are safety issues, but they're worth weighing before you sign up.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Sources

The primary regulatory filings and peer-reviewed studies cited throughout this HealthSource review:

Sources & methodology — as of October 2026
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
  2. 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
  4. 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
  5. 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
  6. 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
  7. 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  8. 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  9. 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
  10. 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  11. 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  12. 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.

See HealthSource's current pricing

Plans start at $199/month. Start your free consultation to check eligibility and today's price.